Press Release
Lund, Sweden, October 14, 2025
ImmuneBiotech’s Precision Probiotic GutMagnific® Now Available at Apoteket AB Marking a Major Milestone for Swedish Science and Health Innovation
ImmuneBiotech Medical Sweden AB, a pioneer in precision probiotics and microbiome-based therapeutics, proudly announces the launch of its flagship product GutMagnific® at Apoteket AB, one of Sweden’s largest and most trusted pharmacy chains.
This marks a pivotal moment for ImmuneBiotech, as years of advanced research, product development, and real-world success now make GutMagnific® accessible nationwide through Apoteket’s online platform.
“This is a proud milestone for ImmuneBiotech and for me personally as a scientist and founder,” says Dr. Shahram Lavasani, CEO of ImmuneBiotech. “Apoteket’s decision to include GutMagnific® following their standard product review and approval process is an important recognition of the product’s quality and reliability. It reflects the dedication of our team and the growing trust among customers who value science-based health solutions.”
GutMagnific®, developed and produced in Sweden, now stands as one of the first Precision Probiotics available through Apoteket, representing an important step in making ImmuneBiotech’s Swedish innovation and scientific excellence more widely available to consumers across the country.
Consumers can now order GutMagnific® online nationwide through Apoteket’s webshop:
Köp GutMagnific Mjölksyrabakterier, 30 st | Apoteket.se
Local Partnership Expands Access in Lund
In parallel with the national launch, ImmuneBiotech also announces a collaboration with Brunnshögs Apotek in Lund, the first physical pharmacy to offer both GutMagnific® and GutMagnific®-KIDS in-store.
“We are thrilled to partner with ImmuneBiotech, a local company leading global microbiome innovation from right here in Lund,” says Rana Sager, Founder and Pharmacist at Brunnshögs Apotek. “Our vision is to make scientifically developed, high-quality health products from the Lund–Malmö research region available to everyone. This collaboration aligns perfectly with our commitment to bring the best in health and innovation to our customers.”
“Choosing Brunnshögs Apotek was a strategic decision,” adds Dr. Lavasani. “It’s one of the fastest-growing independent pharmacies in Lund, known for its exceptional customer service and top-rated reputation. We are proud to see our products available there first, right where our research was born.”
A Milestone on the Road to Growth
“This is a significant step for ImmuneBiotech,” says Rickard Mosell, Chairman of the Board. “The listing at Apoteket AB and the collaboration with Brunnshögs Apotek reflect not only the outstanding quality of GutMagnific® but also ImmuneBiotech’s strong commercial momentum. It demonstrates how scientific excellence can successfully translate into market leadership, nationally and soon internationally.”
Dr. Lavasani adds: “This launch also marks an important milestone in our broader B2B strategy, building collaborations both locally and nationally, while expanding internationally. We are excited about what lies ahead as ImmuneBiotech continues to grow and deliver innovative, science-based microbiome products that make a real difference for people’s health.”
About ImmuneBiotech AB
ImmuneBiotech Medical Sweden AB stands at the forefront of microbiome and probiotics innovation, dedicated to transforming human health through science-based precision solutions.
Founded by immunologist Dr. Shahram Lavasani at Medicon Village in Lund, ImmuneBiotech develops and markets precision-designed probiotic products targeting complex health challenges, particularly within the gut–brain–immune axis.
With over 20 years of pioneering research, ImmuneBiotech has created ImmuneBiotics®, a new category of precision probiotics engineered to restore gut balance, reduce inflammation, and improve systemic wellbeing. The company’s flagship product, GutMagnific®, has been clinically validated and shown to significantly relieve gastrointestinal and neurological symptoms in multiple studies.
GutMagnific®: Transforming Human Health with Precision Probiotics
A scientifically developed, multi-strain probiotic product designed to restore gut microbiome balance, strengthen the intestinal barrier, and modulate the immune system. GutMagnific® is based on two decades of research and validated in double-blind, placebo-controlled clinical trials conducted in collaboration with the Karolinska Institute and Lund University.
Learn more at www.ImmuneBiotech.com and www.GutMagnific.com
For further information, please contact:
Dr. Shahram Lavasani, CEO
ImmuneBiotech Medical Sweden AB
s.lavasani@immunebiotech.com
+46 700 90 8946